Transaction · 0001171843-26-006472

Nijhawan Pardeep

Nijhawan Pardeep, CEO, reported a transaction classified as grant at Edesa Biotech, Inc. involving 6893.000000 shares for an estimated $0.00. Reported holdings after the transaction were 905993.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
EDSAEdesa Biotech, Inc.
Filing timeOct 06
Trade dateOct 05, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$4.01
Pre-filing
1mo ago +18.0%1w ago -9.0%1d ago +0.0%
Returns since
7d30d90d180d1y

EDSA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
EDSA since 2026-10-06Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001171843-26-006472
Common Shares
Transaction date
Oct 05, 2026
Filed Oct 06, 2026, 09:05 PM · 1d delay
Shares
6.89k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
905k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.

  2. F2F3(2 footnotes)

    Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of th…

Original filing · 0001171843-26-006472
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

EDSA